Dear Editor,

Almost all reports on liver injury in patients with 2019 coronavirus disease (COVID-19) found blood liver tests to be frequently abnormal, especially in patients with more severe disease, but with substantial heterogeneity \[[@CR1]\]. Moreover, blood liver tests' abnormalities were frequently thought to be of doubtful clinical value.

Most studies have described blood liver tests in a single time point, usually at inclusion \[[@CR2], [@CR3]\]. Therefore, we used our case series of the first 20 consecutive patients with COVID-19 admitted to the intensive care unit (ICU) at Curry Cabral Hospital in Lisbon, Portugal, from March 10, 2020, onwards, to describe the temporal evolution of blood liver tests.

Median (interquartile range (IQR)) age was 67 (52--74) years with 18 (90%) males (Table [1](#Tab1){ref-type="table"}). Median (IQR) time from symptom onset to hospital admission was 7.5 (5.5--8.5) days, and median time from hospital admission to ICU admission was 1.1 (0.7--2.1) days. All patients required invasive mechanical ventilation on ICU admission. Median (IQR) sequential organ failure assessment (SOFA) score on ICU admission and peak was 8 (7--9) and 9 (8--11), respectively. As of April 10, following a median (IQR) of 21.5 (11.2--25.4) days post ICU admission, 3 (15%) patients died of multi-organ failure, 14 (70%) were discharged to the ward, and 3 (15%) remained in the ICU. Table 1Baseline characteristics and outcomes of patientsCharacteristicMedian (IQR) or *n* (%)Age (years)67 (52--74)Sex (male)18 (90%)BMI (kg/m^2^)29 (26--32)Parameters on ICU admission P~a~O~2~/FiO~2~138 (128--163) Lactate (mmol/L)1.1 (0.8--1.2) Creatinine (mg/dL)1.11 (1.04--1.26)Organ support during ICU stay Invasive mechanical ventilation20 (100%) Vasopressors19 (95%) Renal replacement therapy7 (35%)SOFA score ICU admission8 (7--9) Peak9 (8--11) ICU discharge3 (2--6)APACHEII score18 (14--21)ICU mortality3 (15%)Hospital mortality3 (15%)ICU length of stay (days)10.3 (8.0--12.3)Hospital length of stay (days)22.4 (14.1--26.7)*IQR* interquartile range, *BMI* body mass index, *P*~*a*~*O*~*2*~*/FiO2* oxygen partial pressure/oxygen inspired fraction, *SOFA* Sequential Organ Failure Assessment, *ICU* intensive care unit, *APACHEII* Acute Physiology and Chronic Health Evaluation II

No patient had documented liver disease prior to hospitalization. During the first 10 days post ICU admission, all patients had at least one abnormal blood liver test. Overtime, only median gamma-glutamiltranspeptidase (GGT), alanine transferase (ALT), and aspartate transferase (AST) showed any increase from upper limit of normal (ULN) and only median GGT had a ≥ 3 fold increase from ULN (Table [2](#Tab2){ref-type="table"}). Median peak GGT was on day 8 post ICU admission. Patients with peak C-reactive protein ≥ 250 mg/L (day 4 post ICU admission) had higher but non-significant median peak GGT (298 vs. 125 IU/L), ALT (101 vs. 42 IU/L), or AST (72 vs. 57 IU/L) than others (*P* \> 0.50 for all comparisons). Table 2Temporal evolution of median levels of blood testsTest (upper limit of normal)H admICU admD2D3D4D5D6D7D8D9D10INR (≤ 1.2)1.181.171.201.161.171.181.171.151.171.171.16Bilirubin (≤ 1.2 mg/dL)0.650.801.011.160.800.861.050.921.150.870.97ALP (≤ 150 IU/L)61596174838910195116125111GGT (≤ 64 IU/L)555253669273102214237211225ALT (≤ 55 IU/L)3130333143485667825572AST (≤ 34 IU/L)5151514449576962605346CRP (≤ 5 mg/L)176207239257271258198153977674*H adm* hospital admission, *ICU adm* intensive care unit admission, *INR* international normalized ratio, *ALP* alkaline phosphatase, *GGT* gamma-glutamiltranspeptidase, *ALT* alanine aminotransferase, *AST* aspartate aminotransferase, *CRP* C-reactive protein

In our case series, liver injury was frequent but generally transient and non-severe. While synthetic function was largely preserved, late cholestasis was frequently observed. Cholestasis may have been associated to the critical illness itself (inflammation), parenteral nutrition (only 2 patients required parenteral nutrition), or drug toxicity (all patients were on antibiotics, for example ceftriaxone, amoxicillin-clavulanate, or azithromycin) \[[@CR4], [@CR5]\]. While cholestasis could have been multifactorial, the differential diagnosis was not easy to perform with precision. Overall, attention to modifiable factors, such as control of inflammation, timing of parenteral nutrition, and avoiding drugs with worse liver toxicity profile, may be important to prevent cholestasis progression in these patients. Further studies are needed to understand liver injury in critically ill patients with COVID-19, especially if there is any direct viral effect on the liver cells.
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